Low-T Testosterone Therapy Side Effects

New research suggests that testosterone treatments for men may have significant side effects, including:
  • increased risk for stroke;
  • increased risk for blood clots;
  • increased risk for heart attack; and
  • increased risk for death.
In 2011, more than 5,000,000 prescriptions for testosterone were written in the United States.  On January 30, 2014, the U.S. Food and Drug Administration announced that it was investigating "serious adverse cardiovascular outcomes" in patients receiving TRT.  The FDA's investigation follows two recently published studies:

  • Study One: Suggests that men treated with TRT are significantly more likely to have a myocardial infarction (MI or heart attack) in the first 90 days after starting the medication.  In the three months after start of TRT, the risk of MI was increased by 36%.  Further, in patients over age 65, the risk of MI was even higher.
  • Study Two: An observational analysis of Veterans Affairs (VA) patients found that testosterone therapy in men was linked with an increased risk of death, heart attack, or ischemic stroke.

If TRT manufacturers knew or should have known of the risks and did not disclose all-together, or provided an inadequate warning to physicians and consumers on bottles and package inserts, they may be liable for damages, including compensation for:

  • pain and suffering;
  • lost wages;
  • medical bills; and
  • wrongful death.

To speak with a member of our legal team to learn more about whether your use of AndroGel, Androderm, Axiron, Androud 10, Depo-Testosterone, Bio-T-Gel, Delatestryl, Fortesta, Straint, Testin or Testopel caused a cardiac or embolic event, contact us at (800) 336-5297, or by email at info@bottarleone.com.